Good morning, Nina Lindholm here with the Europe Wire from the London newsroom.
During the pandemic years, many of us became acutely aware of our respiratory health, particularly in relation to how covid-19 could exacerbate pre-existing conditions. This morning, we kick things off with an exit in that very field, with Aksìa’s sale of an Italian spirometry company.
The IPO market has remained tepid for quite some time, but there might be some signs of light, based on figures from S&P Global Market Intelligence. We delve into the global fourth-quarter numbers this morning.
We’ll round things out with some people news, as AIP Management has promoted four of its team members as partners.
Exhale
Aksìa has completed the sale of Medical International Research (MIR), a spirometry business.The company’s shares were acquired by Quadrivio’s Silver Economy Fund, alongside a group of co-investors.
For more on the deal, take a look at the premium Wire coverage here.
IPO increase
Keeping with the exit theme, let’s look at figures around IPOs. European IPO activity increased in the fourth quarter of 2024, according to S&P Global Market Intelligence.
For my takeaways from the report, check out the full Wire coverage here.
New year, new role
January is a big month for promotions, and PE Hub has already reported on a slew of them over the past few weeks. We have a fresh one this morning, with AIP Management announcing four promotions.
To learn more, take a look at the premium Wire here.
That’s all from me. Rafael Canton will be on US Wire duty later today, and I’ll bring you the Europe edition tomorrow as usual.
Cheers,
Nina
Read the full Wire commentary on PE Hub ...
